We are live on
!
Find out more
FBC
Fairfield, Bush & Co Portfolio holdings
AUM
$180M
1-Year Est. Return
39.51%
This Fund
S&P 500
This Quarter
Est. Return
+12.12%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$171M
AUM Growth
+$17.5M
(+11%)
Cap. Flow
+$1.12M
Cap. Flow
% of AUM
0.66%
Top 10 Holdings %
Top 10 Hldgs %
36.71%
Holding
532
New
422
Increased
22
Reduced
72
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$822K |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$542K |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$516K |
| 4 |
ExxonMobil
XOM
|
+$395K |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$351K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$1.35M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$972K |
| 3 |
Microsoft
MSFT
|
+$892K |
| 4 |
JPMorgan Chase
JPM
|
+$843K |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$810K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.84% |
| 2 | Healthcare | 14.53% |
| 3 | Consumer Staples | 13.76% |
| 4 | Financials | 8.41% |
| 5 | Consumer Discretionary | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
EOG Resources
EOG
$76.5B
| $8.02K | ﹤0.01% |
+66
| New | +$8.22K |
|
327
Timken Company
TKR
$9.1B
| $8.02K | ﹤0.01% |
+100
| New | +$7.36K |
|
328
UnitedHealth
UNH
$371B
| $7.9K | ﹤0.01% |
+15
| New | +$8K |
|
329
Vodafone
VOD
$36.2B
| $7.68K | ﹤0.01% |
+883
| New | +$8.07K |
|
330
Vontier
VNT
$4.71B
| $7.6K | ﹤0.01% |
+220
| New | +$7.16K |
|
331
Biohaven
BHVN
$2.04B
| $7.28K | ﹤0.01% |
+170
| New | +$5.29K |
|
332
SBA Communications
SBAC
$19.7B
| $7.1K | ﹤0.01% |
+28
| New | +$6.29K |
|
333
Flywire
FLYW
$2.08B
| $7.08K | ﹤0.01% |
+306
| New | +$7.72K |
|
|
NVTA
334
DELISTED
Invitae Corporation
NVTA
| $6.88K | ﹤0.01% |
10,980
| – | – |
|
|
VPU
335
Vanguard Utilities ETF
VPU
$8.41B
| $6.85K | ﹤0.01% |
+50
| New | +$6.6K |
|
336
Clorox
CLX
$12.2B
| $6.84K | ﹤0.01% |
+48
| New | +$6.4K |
|
337
Silgan Holdings
SLGN
$4.44B
| $6.79K | ﹤0.01% |
+150
| New | +$6.32K |
|
|
FBRT
338
Franklin BSP Realty Trust
FBRT
$638M
| $6.66K | ﹤0.01% |
+493
| New | +$6.5K |
|
339
PENN Entertainment
PENN
$2.7B
| $6.63K | ﹤0.01% |
+255
| New | +$5.91K |
|
340
S&P Global
SPGI
$123B
| $6.61K | ﹤0.01% |
+15
| New | +$5.92K |
|
341
Newmont
NEM
$103B
| $6.42K | ﹤0.01% |
+155
| New | +$5.98K |
|
342
Molson Coors Class B
TAP
$7.87B
| $6.12K | ﹤0.01% |
+100
| New | +$6.01K |
|
343
Teradata
TDC
$3.14B
| $5.83K | ﹤0.01% |
+134
| New | +$6.02K |
|
344
Oscar Health
OSCR
$9.17B
| $5.49K | ﹤0.01% |
+600
| New | +$4.14K |
|
345
iShares US Real Estate ETF
IYR
$4.65B
| $5.49K | ﹤0.01% |
+60
| New | +$4.91K |
|
346
Micron Technology
MU
$1.01T
| $5.38K | ﹤0.01% |
+63
| New | +$4.68K |
|
|
NIE
347
Virtus Equity & Convertible Income Fund
NIE
$728M
| $5.23K | ﹤0.01% |
+250
| New | +$5.07K |
|
348
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $5.16K | ﹤0.01% |
+250
| New | +$4.73K |
|
349
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $5.11K | ﹤0.01% |
+101
| New | +$4.89K |
|
350
Cardinal Health
CAH
$55B
| $5.04K | ﹤0.01% |
+50
| New | +$4.96K |
|
Similar funds
KCM
AG
AIC
PCA
HIC
V
RVM
FFA
Fairfield, Bush & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Fairfield, Bush & Co held 532 positions worth $171M, up 11% from $153M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Fairfield, Bush & Co's Q4 2023 filing shows 422 new, 22 increased, 72 reduced and 2 closed positions. Its largest new stake was iShares Russell 2000 ETF: 3,027 shares worth $608K. The largest sale was Seagen Inc. Common Stock, an estimated $1.35M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.
- Fairfield, Bush & Co's largest Q4 2023 buy was iShares Russell 2000 ETF: 3,027 shares worth $608K.
- Fairfield, Bush & Co added most to Novo Nordisk in Q4 2023, an estimated $822K increase.
- Fairfield, Bush & Co's biggest Q4 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $1.35M.
- Fairfield, Bush & Co fully exited Activision Blizzard in Q4 2023, selling an estimated $810K.
- Fairfield, Bush & Co's ten largest holdings make up 37% of its $171M portfolio in Q4 2023.
- Fairfield, Bush & Co opened 422 new positions and closed 2 in Q4 2023.
- Fairfield, Bush & Co's portfolio value rose 11% quarter-over-quarter to $171M.
Based on Fairfield, Bush & Co's 13F filing for Q4 2023, filed 13 Feb 2024.